Search

Your search keyword '"Nguyen, Linh T."' showing total 482 results

Search Constraints

Start Over You searched for: Author "Nguyen, Linh T." Remove constraint Author: "Nguyen, Linh T."
482 results on '"Nguyen, Linh T."'

Search Results

2. Blockchain-Empowered Trustworthy Data Sharing: Fundamentals, Applications, and Challenges

4. Identification of antigenic epitopes recognized by tumor infiltrating lymphocytes in high grade serous ovarian cancer by multi-omics profiling of the auto-antigen repertoire

10. Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial

12. Coenzyme A fuels T cell anti-tumor immunity

13. Generation of an Inhibitory NK Cell Subset by TGF-β1/IL-15 Polarization

14. A distinct innate lymphoid cell population regulates tumor-associated T cells

15. Strategy for Sustaining Cancer Education Services for Underserved Communities.

16. Biochar-based catalysts: a potential disposal of plant biomass from phytoremediation.

17. The biological and therapeutic assessment of a P(3HB‐co‐4HB)‐bioactive glass‐graphene composite biomaterial for tissue regeneration.

24. An Improved Algorithm for Mining Top-k Association Rules

26. Threshold level of Peptest in diagnosing gastroesophageal reflux disease with extraesophageal symptoms: Evidence from Vietnam

30. Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2

37. A novel population of CD103-expressing CD56 +regulatory ILCs suppresses intratumoural T cells and are associated with poor prognosis in patients with ovarian carcinoma

38. Data from IL6 Induces an IL22+ CD8+ T-cell Subset with Potent Antitumor Function

39. Supplementary Figures and Tables from IL6 Induces an IL22+ CD8+ T-cell Subset with Potent Antitumor Function

40. Figure S6 from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma

41. Supplementary Figure 2 from Activation of Peroxisome Proliferator-Activated Receptors α and δ Synergizes with Inflammatory Signals to Enhance Adoptive Cell Therapy

42. Supplementary Figure 2 from Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors

43. Supplementary Table 1 from Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors

45. Supplementary Figure 1 from Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors

47. Supplemental Figure legends from Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma

49. Supplementary Figure 3 from Activation of Peroxisome Proliferator-Activated Receptors α and δ Synergizes with Inflammatory Signals to Enhance Adoptive Cell Therapy

50. Supplementary Figure 1 from Activation of Peroxisome Proliferator-Activated Receptors α and δ Synergizes with Inflammatory Signals to Enhance Adoptive Cell Therapy

Catalog

Books, media, physical & digital resources